Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 1,854

The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.

2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death

Open access
Al-Khatib, Sana M., Stevenson, William G., Ackerman, Michael J., Bryant, William J., Callans, David J., Curtis, Anne B., Deal, Barbara J., Dickfeld, Timm, Field, Michael E., Fonarow, Gregg C., Gillis, Anne M., Granger, Christopher B., Hammill, Stephen C., Hlatky, Mark A., Joglar, José A., Kay, G. Neal, Matlock, Daniel D., Myerburg, Robert J., Page, Richard L.·2018·Journal of the American College of Cardiology
DOI 10.1016/j.jacc.2017.10.054
Open this paper in CoChat — free account

Abstract

Glenn N. Levine, MD, FACC, FAHA, Chair Patrick T. O’Gara, MD, MACC, FAHA, Chair-Elect Jonathan L. Halperin, MD, FACC, FAHA, Immediate Past Chair [¶][1] Sana M. Al-Khatib, MD, MHS, FACC, FAHA Joshua A. Beckman, MD, MS, FAHA Kim K. Birtcher, MS, PharmD, AACC Biykem Bozkurt, MD, PhD, FACC,

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2017.10.054

Cites

91 of 91 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 91 references

Research works printed but not linked: 1163

  1. Anderson, 2014, ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines, J Am Coll Cardiol, 63, 2304, 10.1016/j.jacc.2014.03.016 · DOI · Paper page
  2. Arnett, 2014, J Am Coll Cardiol, 64, 1851, 10.1016/j.jacc.2014.07.012 · DOI · Paper page
  3. Jacobs, 2013, ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol, 61, 213, 10.1016/j.jacc.2012.09.025 · DOI · Paper page
  4. Kusumoto, 2018, J Am Coll Cardiol, 72, 1653, 10.1016/j.jacc.2017.10.052 · DOI
  5. Anderson, 2014, ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines, J Am Coll Cardiol, 63, 2304, 10.1016/j.jacc.2014.03.016 · DOI · Paper page
  6. Zipes, 2006, J Am Coll Cardiol, 48, e247, 10.1016/j.jacc.2006.07.010 · DOI · Paper page
  7. Gersh, 2011, J Am Coll Cardiol, 58, e212, 10.1016/j.jacc.2011.06.011 · DOI · Paper page
  8. Buxton, 2006, J Am Coll Cardiol, 48, 2360, 10.1016/j.jacc.2006.09.020 · DOI · Paper page
  9. Piccini, 2016, Wearable cardioverter-defibrillator therapy for the prevention of sudden cardiac death: a science advisory from the American Heart Association, Circulation, 133, 1715, 10.1161/CIR.0000000000000394 · DOI
  10. Yancy, 2017, J Am Coll Cardiol, 70, 776, 10.1016/j.jacc.2017.04.025 · DOI · Paper page
  11. Yancy, 2016, J Am Coll Cardiol, 68, 1476, 10.1016/j.jacc.2016.05.011 · DOI · Paper page
  12. Nishimura, 2017, 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, J Am Coll Cardiol, 70, 252, 10.1016/j.jacc.2017.03.011 · DOI · Paper page
  13. Priori, 2016, G Ital Cardiol (Rome), 17, 108
  14. Perkins, 2015, Circulation, 132, 1286, 10.1161/CIR.0000000000000144 · DOI · Paper page
  15. January, 2014, 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society, J Am Coll Cardiol, 64, e1, 10.1016/j.jacc.2014.03.022 · DOI · Paper page
  16. Amsterdam, 2014, 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol, 64, e139, 10.1016/j.jacc.2014.09.017 · DOI · Paper page
  17. Andrus, 2014, 2013 ACC/AHA guideline on the assessment of cardiovascular risk, J Am Coll Cardiol, 63, 2886, 10.1016/j.jacc.2014.02.606 · DOI
  18. Steg, 2012, ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation, Eur Heart J, 33, 2569, 10.1093/eurheartj/ehs215 · DOI · Paper page
  19. Tracy, 2012, 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol, 60, 1297, 10.1016/j.jacc.2012.07.009 · DOI · Paper page
  20. Hillis, 2011, J Am Coll Cardiol, 58, e123, 10.1016/j.jacc.2011.08.009 · DOI · Paper page
  21. Levine, 2013, 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions, Catheter Cardiovasc Interv, 82, E266, 10.1002/ccd.23390 · DOI
  22. Smith, 2011, AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation, J Am Coll Cardiol, 58, 2432, 10.1016/j.jacc.2011.10.824 · DOI · Paper page
  23. Link, 2015, Circulation, 132, e334
  24. Kusumoto, 2014, HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials, J Am Coll Cardiol, 64, 1143, 10.1016/j.jacc.2014.04.008 · DOI
  25. Birnie, 2014, HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis, Heart Rhythm, 11, 1305, 10.1016/j.hrthm.2014.03.043 · DOI · Paper page
  26. Priori, 2013, HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes, Heart Rhythm, 10, 1932, 10.1016/j.hrthm.2013.05.014 · DOI · Paper page
  27. Myerburg, 2012, Sudden cardiac death caused by coronary heart disease, Circulation, 125, 1043, 10.1161/CIRCULATIONAHA.111.023846 · DOI · Paper page
  28. Buxton, 2006, ACC/AHA/HRS 2006 key data elements and definitions for electrophysiological studies and procedures: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards, J Am Coll Cardiol, 48, 2360, 10.1016/j.jacc.2006.09.020 · DOI · Paper page
  29. Sapp, 2016, Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs, N Engl J Med, 375, 111, 10.1056/NEJMoa1513614 · DOI · Paper page
  30. Priori, 2013, HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes, Heart Rhythm, 10, 1932, 10.1016/j.hrthm.2013.05.014 · DOI · Paper page
  31. Hiss, 1962, Electrocardiographic findings in 122,043 individuals, Circulation, 25, 947, 10.1161/01.CIR.25.6.947 · DOI · Paper page
  32. Brodsky, 1977, Arrhythmias documented by 24 hour continuous electrocardiographic monitoring in 50 male medical students without apparent heart disease, Am J Cardiol, 39, 390, 10.1016/S0002-9149(77)80094-5 · DOI · Paper page
  33. Massing, 2006, Usefulness of ventricular premature complexes to predict coronary heart disease events and mortality (from the Atherosclerosis Risk In Communities cohort), Am J Cardiol, 98, 1609, 10.1016/j.amjcard.2006.06.061 · DOI
  34. Ofoma, 2012, Premature cardiac contractions and risk of incident ischemic stroke, J Am Heart Assoc, 1, e002519, 10.1161/JAHA.112.002519 · DOI
  35. Ataklte, 2013, Meta-analysis of ventricular premature complexes and their relation to cardiac mortality in general populations, Am J Cardiol, 112, 1263, 10.1016/j.amjcard.2013.05.065 · DOI · Paper page
  36. Lin, 2015, Long-term outcome of multiform premature ventricular complexes in structurally normal heart, Int J Cardiol, 180, 80, 10.1016/j.ijcard.2014.11.110 · DOI
  37. Lin, 2016, Long-term outcome of non-sustained ventricular tachycardia in structurally normal hearts, PloS One, 11, e0160181, 10.1371/journal.pone.0160181 · DOI
  38. Ruberman, 1981, Ventricular premature complexes and sudden death after myocardial infarction, Circulation, 64, 297, 10.1161/01.CIR.64.2.297 · DOI · Paper page
  39. Ruberman, 1977, Ventricular premature beats and mortality after myocardial infarction, N Engl J Med, 297, 750, 10.1056/NEJM197710062971404 · DOI · Paper page
  40. 1992, Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. The Cardiac Arrhythmia Suppression Trial II Investigators, N Engl J Med, 327, 227, 10.1056/NEJM199207233270403 · DOI · Paper page
  41. Echt, 1991, Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial, N Engl J Med, 324, 781, 10.1056/NEJM199103213241201 · DOI · Paper page
  42. Morganroth, 1991, Quinidine-related mortality in the short-to-medium-term treatment of ventricular arrhythmias. A meta-analysis, Circulation, 84, 1977, 10.1161/01.CIR.84.5.1977 · DOI
  43. Waldo, 1996, Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol, Lancet, 348, 7, 10.1016/S0140-6736(96)02149-6 · DOI · Paper page
  44. Ling, 2014, Radiofrequency ablation versus antiarrhythmic medication for treatment of ventricular premature beats from the right ventricular outflow tract: prospective randomized study, Circ Arrhythm Electrophysiol, 7, 237, 10.1161/CIRCEP.113.000805 · DOI · Paper page
  45. Jouven, 2000, Long-term outcome in asymptomatic men with exercise-induced premature ventricular depolarizations, N Engl J Med, 343, 826, 10.1056/NEJM200009213431201 · DOI · Paper page
  46. Frolkis, 2003, Frequent ventricular ectopy after exercise as a predictor of death, N Engl J Med, 348, 781, 10.1056/NEJMoa022353 · DOI · Paper page
  47. Kanei, 2008, Frequent premature ventricular complexes originating from the right ventricular outflow tract are associated with left ventricular dysfunction, Ann Noninvasive Electrocardiol, 13, 81, 10.1111/j.1542-474X.2007.00204.x · DOI
  48. Lee, 2012, Premature ventricular contraction-induced cardiomyopathy: a treatable condition, Circ Arrhythm Electrophysiol, 5, 229, 10.1161/CIRCEP.111.963348 · DOI
  49. Viskin, 2005, The “short-coupled” variant of right ventricular outflow ventricular tachycardia: a not-so-benign form of benign ventricular tachycardia?, J Cardiovasc Electrophysiol, 16, 912, 10.1111/j.1540-8167.2005.50040.x · DOI · Paper page
  50. Noda, 2005, Malignant entity of idiopathic ventricular fibrillation and polymorphic ventricular tachycardia initiated by premature extrasystoles originating from the right ventricular outflow tract, J Am Coll Cardiol, 46, 1288, 10.1016/j.jacc.2005.05.077 · DOI · Paper page
  51. Dumas, 2010, Immediate percutaneous coronary intervention is associated with better survival after out-of-hospital cardiac arrest: insights from the PROCAT (Parisian Region Out of hospital Cardiac ArresT) registry, Circ Cardiovasc Interv, 3, 200, 10.1161/CIRCINTERVENTIONS.109.913665 · DOI · Paper page
  52. Gupta, 2010, Incidence of, predictors for, and mortality associated with malignant ventricular arrhythmias in non-ST elevation myocardial infarction patients, Coron Artery Dis, 21, 460, 10.1097/MCA.0b013e32834022fa · DOI
  53. Terkelsen, 2009, Prevalence and significance of accelerated idioventricular rhythm in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention, Am J Cardiol, 104, 1641, 10.1016/j.amjcard.2009.07.037 · DOI
  54. Al-Khatib, 2002, Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomes, Circulation, 106, 309, 10.1161/01.CIR.0000022692.49934.E3 · DOI
  55. Jabbari, 2015, Incidence and risk factors of ventricular fibrillation before primary angioplasty in patients with first ST-elevation myocardial infarction: a nationwide study in Denmark, J Am Heart Assoc, 4, e001399, 10.1161/JAHA.114.001399 · DOI
  56. Mehta, 2009, Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention, JAMA, 301, 1779, 10.1001/jama.2009.600 · DOI · Paper page
  57. Volpi, 1989, One-year prognosis of primary ventricular fibrillation complicating acute myocardial infarction. The GISSI (Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto miocardico) investigators, Am J Cardiol, 63, 1174, 10.1016/0002-9149(89)90174-4 · DOI
  58. El-Sherif, 1981, Canine ventricular arrhythmias in the late myocardial infarction period. 8. Epicardial mapping of reentrant circuits, Circ Res, 49, 255, 10.1161/01.RES.49.1.255 · DOI · Paper page
  59. Ackerman, 2011, HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA), Europace, 13, 1077, 10.1093/europace/eur245 · DOI · Paper page
  60. Nannenberg, 2012, Mortality of inherited arrhythmia syndromes: insight into their natural history, Circ Cardiovasc Genet, 5, 183, 10.1161/CIRCGENETICS.111.961102 · DOI
  61. Haïssaguerre, 2002, Role of Purkinje conducting system in triggering of idiopathic ventricular fibrillation, Lancet, 359, 677, 10.1016/S0140-6736(02)07807-8 · DOI · Paper page
  62. Haïssaguerre, 2002, Mapping and ablation of idiopathic ventricular fibrillation, Circulation, 106, 962, 10.1161/01.CIR.0000027564.55739.B1 · DOI · Paper page
  63. Goldberger, 2011, Risk stratification for arrhythmic sudden cardiac death: identifying the roadblocks, Circulation, 123, 2423, 10.1161/CIRCULATIONAHA.110.959734 · DOI · Paper page
  64. Fishman, 2010, Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop, Circulation, 122, 2335, 10.1161/CIRCULATIONAHA.110.976092 · DOI · Paper page
  65. Myerburg, 2001, Sudden cardiac death: exploring the limits of our knowledge, J Cardiovasc Electrophysiol, 12, 369, 10.1046/j.1540-8167.2001.00369.x · DOI · Paper page
  66. Kong, 2011, Systematic review of the incidence of sudden cardiac death in the United States, J Am Coll Cardiol, 57, 794, 10.1016/j.jacc.2010.09.064 · DOI · Paper page
  67. Benjamin, 2017, Heart disease and stroke statistics—2017 update: a report from the American Heart Association, Circulation, 135, e146, 10.1161/CIR.0000000000000485 · DOI · Paper page
  68. Merchant, 2011, Incidence of treated cardiac arrest in hospitalized patients in the United States, Crit Care Med, 39, 2401, 10.1097/CCM.0b013e3182257459 · DOI · Paper page
  69. Jollis, 2016, Improving care of out-of-hospital cardiac arrest: next steps, Circulation, 134, 2040, 10.1161/CIRCULATIONAHA.116.025818 · DOI
  70. Myerburg, 2013, Pulseless electric activity: definition, causes, mechanisms, management, and research priorities for the next decade: report from a National Heart, Lung, and Blood Institute workshop, Circulation, 128, 2532, 10.1161/CIRCULATIONAHA.113.004490 · DOI
  71. Myerburg, 2017, Sudden cardiac arrest risk assessment: population science and the individual risk mandate, JAMA Cardiol, 2, 689, 10.1001/jamacardio.2017.0266 · DOI
  72. Junttila, 2016, Temporal trends in the clinical and pathological characteristics of victims of sudden cardiac death in the absence of previously identified heart disease, Circ Arrhythm Electrophysiol, 9, e003723, 10.1161/CIRCEP.115.003723 · DOI
  73. Hookana, 2011, Causes of nonischemic sudden cardiac death in the current era, Heart Rhythm, 8, 1570, 10.1016/j.hrthm.2011.06.031 · DOI
  74. Wong, 2014, Trends in short- and long-term survival among out-of-hospital cardiac arrest patients alive at hospital arrival, Circulation, 130, 1883, 10.1161/CIRCULATIONAHA.114.010633 · DOI
  75. Cherry, 2012, Mechanisms of ventricular arrhythmias: a dynamical systems-based perspective, Am J Physiol Heart Circ Physiol, 302, H2451, 10.1152/ajpheart.00770.2011 · DOI
  76. Pandit, 2013, Rotors and the dynamics of cardiac fibrillation, Circ Res, 112, 849, 10.1161/CIRCRESAHA.111.300158 · DOI · Paper page
  77. Tsuji, 2013, Electrical storm: recent pathophysiological insights and therapeutic consequences, Basic Res Cardiol, 108, 336, 10.1007/s00395-013-0336-2 · DOI
  78. Roden, 2016, Predicting drug-induced QT prolongation and torsades de pointes, J Physiol, 594, 2459, 10.1113/JP270526 · DOI
  79. Antzelevitch, 2014, The role of late I Na in development of cardiac arrhythmias, Handb Exp Pharmacol, 221, 137, 10.1007/978-3-642-41588-3_7 · DOI
  80. Lerman, 2015, Mechanism, diagnosis, and treatment of outflow tract tachycardia, Nat Rev Cardiol, 12, 597, 10.1038/nrcardio.2015.121 · DOI
  81. Priori, 2011, Inherited dysfunction of sarcoplasmic reticulum Ca2+ handling and arrhythmogenesis, Circ Res, 108, 871, 10.1161/CIRCRESAHA.110.226845 · DOI · Paper page
  82. Nogami, 2011, Purkinje-related arrhythmias part I: monomorphic ventricular tachycardias, Pacing Clin Electrophysiol, 34, 624, 10.1111/j.1540-8159.2011.03044.x · DOI · Paper page
  83. Haissaguerre, 2016, Ventricular arrhythmias and the His-Purkinje system, Nat Rev Cardiol, 13, 155, 10.1038/nrcardio.2015.193 · DOI · Paper page
  84. Tabereaux, 2009, Mechanisms of VF maintenance: wandering wavelets, mother rotors, or foci, Heart Rhythm, 6, 405, 10.1016/j.hrthm.2008.11.005 · doi:10.1016/j.hrthm.2008.11.005
  85. Zhang, 2016, Electrophysiologic scar substrate in relation to VT: noninvasive high-resolution mapping and risk assessment with ECGI, Pacing Clin Electrophysiol, 39, 781, 10.1111/pace.12882 · doi:10.1111/pace.12882
  86. Fernandez-Armenta, 2016, Substrate modification or ventricular tachycardia induction, mapping, and ablation as the first step? A randomized study, Heart Rhythm, 13, 1589, 10.1016/j.hrthm.2016.05.013 · DOI
  87. Myerburg, 2015, Cardiac arrest and sudden cardiac death - Chapter 39, 821
  88. Noda, 2005, Malignant entity of idiopathic ventricular fibrillation and polymorphic ventricular tachycardia initiated by premature extrasystoles originating from the right ventricular outflow tract, J Am Coll Cardiol, 46, 1288, 10.1016/j.jacc.2005.05.077 · DOI · Paper page
  89. Viskin, 2005, The “short-coupled” variant of right ventricular outflow ventricular tachycardia: a not-so-benign form of benign ventricular tachycardia?, J Cardiovasc Electrophysiol, 16, 912, 10.1111/j.1540-8167.2005.50040.x · DOI · Paper page
  90. Konigstein, 2016, Drug-induced Brugada syndrome: clinical characteristics and risk factors, Heart Rhythm, 13, 1083, 10.1016/j.hrthm.2016.03.016 · DOI
  91. Basso, 2015, Arrhythmic mitral valve prolapse and sudden cardiac death, Circulation, 132, 556, 10.1161/CIRCULATIONAHA.115.016291 · DOI · Paper page
  92. Nordhues, 2016, Bileaflet mitral valve prolapse and risk of ventricular dysrhythmias and death, J Cardiovasc Electrophysiol, 27, 463, 10.1111/jce.12914 · doi:10.1111/jce.12914
  93. Sriram, 2013, Malignant bileaflet mitral valve prolapse syndrome in patients with otherwise idiopathic out-of-hospital cardiac arrest, J Am Coll Cardiol, 62, 222, 10.1016/j.jacc.2013.02.060 · DOI · Paper page
  94. Huikuri, 2001, Sudden death due to cardiac arrhythmias, N Engl J Med, 345, 1473, 10.1056/NEJMra000650 · DOI · Paper page
  95. Krahn, 2012, Sentinel symptoms in patients with unexplained cardiac arrest: from the Cardiac Arrest Survivors with Preserved Ejection Fraction Registry (CASPER), J Cardiovasc Electrophysiol, 23, 60, 10.1111/j.1540-8167.2011.02185.x · DOI
  96. Ruwald, 2012, The relation between age, sex, comorbidity, and pharmacotherapy and the risk of syncope: a Danish nationwide study, Europace, 14, 1506, 10.1093/europace/eus154 · DOI · Paper page
  97. Wellens, 1978, The value of the electrocardiogram in the differential diagnosis of a tachycardia with a widened QRS complex, Am J Med, 64, 27, 10.1016/0002-9343(78)90176-6 · DOI · Paper page
  98. Steinman, 1989, Wide QRS tachycardia in the conscious adult. Ventricular tachycardia is the most frequent cause, JAMA, 261, 1013, 10.1001/jama.1989.03420070063031 · DOI
  99. Elhendy, 2002, Functional and prognostic significance of exercise-induced ventricular arrhythmias in patients with suspected coronary artery disease, Am J Cardiol, 90, 95, 10.1016/S0002-9149(02)02428-1 · DOI
  100. Grady, 1998, Prognostic significance of exercise-induced left bundle-branch block, JAMA, 279, 153, 10.1001/jama.279.2.153 · DOI
  101. Perez-Rodon, 2014, Prognostic value of the electrocardiogram in patients with syncope: data from the group for syncope study in the emergency room (GESINUR), Heart Rhythm, 11, 2035, 10.1016/j.hrthm.2014.06.037 · DOI
  102. Baldasseroni, 2002, Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure, Am Heart J, 143, 398, 10.1067/mhj.2002.121264 · DOI · Paper page
  103. Buxton, 2005, QRS duration does not predict occurrence of ventricular tachyarrhythmias in patients with implanted cardioverter-defibrillators, J Am Coll Cardiol, 46, 310, 10.1016/j.jacc.2005.03.060 · DOI
  104. Desai, 2006, Prognostic significance of quantitative QRS duration, Am J Med, 119, 600, 10.1016/j.amjmed.2005.08.028 · DOI
  105. Dhar, 2008, Association of prolonged QRS duration with ventricular tachyarrhythmias and sudden cardiac death in the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II), Heart Rhythm, 5, 807, 10.1016/j.hrthm.2008.02.013 · DOI
  106. Freedman, 1987, Bundle branch block in patients with chronic coronary artery disease: angiographic correlates and prognostic significance, J Am Coll Cardiol, 10, 73, 10.1016/S0735-1097(87)80162-6 · DOI · Paper page
  107. Iuliano, 2002, QRS duration and mortality in patients with congestive heart failure, Am Heart J, 143, 1085, 10.1067/mhj.2002.122516 · DOI · Paper page
  108. Kadish, 2004, Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy, N Engl J Med, 350, 2151, 10.1056/NEJMoa033088 · DOI · Paper page
  109. Zimetbaum, 2004, Electrocardiographic predictors of arrhythmic death and total mortality in the multicenter unsustained tachycardia trial, Circulation, 110, 766, 10.1161/01.CIR.0000139311.32278.32 · DOI · Paper page
  110. Costantini, 2009, The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention, J Am Coll Cardiol, 53, 471, 10.1016/j.jacc.2008.08.077 · DOI
  111. Monasterio, 2013, Prognostic value of average T-wave alternans and QT variability for cardiac events in MADIT-II patients, J Electrocardiol, 46, 480, 10.1016/j.jelectrocard.2013.08.004 · DOI
  112. Gupta, 2012, Ability of microvolt T-wave alternans to modify risk assessment of ventricular tachyarrhythmic events: a meta-analysis, Am Heart J, 163, 354, 10.1016/j.ahj.2011.11.021 · DOI
  113. Bloomfield, 2004, Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum, Circulation, 110, 1885, 10.1161/01.CIR.0000143160.14610.53 · DOI · Paper page
  114. Linzer, 1990, Incremental diagnostic yield of loop electrocardiographic recorders in unexplained syncope, Am J Cardiol, 66, 214, 10.1016/0002-9149(90)90591-N · DOI · Paper page
  115. Solbiati, 2016, Implantable loop recorder versus conventional diagnostic workup for unexplained recurrent syncope, Cochrane Database Syst. Rev, 4
  116. Volosin, 2013, Tachycardia detection performance of implantable loop recorders: results from a large 'real-life' patient cohort and patients with induced ventricular arrhythmias, Europace, 15, 1215, 10.1093/europace/eut036 · DOI
  117. Linzer, 1990, Incremental diagnostic yield of loop electrocardiographic recorders in unexplained syncope, Am J Cardiol, 66, 214, 10.1016/0002-9149(90)90591-N · DOI · Paper page
  118. Turakhia, 2013, Diagnostic utility of a novel leadless arrhythmia monitoring device, Am J Cardiol, 112, 520, 10.1016/j.amjcard.2013.04.017 · DOI · Paper page
  119. Solomon, 2005, Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both, N Engl J Med, 352, 2581, 10.1056/NEJMoa043938 · DOI · Paper page
  120. Gula, 2008, Ejection fraction assessment and survival: an analysis of the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT), Am Heart J, 156, 1196, 10.1016/j.ahj.2008.08.007 · DOI
  121. Shen, 2017, 2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society, J Am Coll Cardiol, 70, e39, 10.1016/j.jacc.2017.03.003 · DOI · Paper page
  122. Coleman, 2016, Prognostic value of myocardial scarring on CMR in patients with cardiac sarcoidosis: a systematic review and meta-analysis, J Am Coll Cardiol Img, 10, 411, 10.1016/j.jcmg.2016.05.009 · DOI · Paper page
  123. Di Marco, 2017, Late gadolinium enhancement and the risk for ventricular arrhythmias or sudden death in dilated cardiomyopathy: systematic review and meta-analysis, JACC Heart Fail, 5, 28, 10.1016/j.jchf.2016.09.017 · DOI · Paper page
  124. Greulich, 2013, CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis, J Am Coll Cardiol Img, 6, 501, 10.1016/j.jcmg.2012.10.021 · DOI · Paper page
  125. Piers, 2013, Contrast-enhanced MRI-derived scar patterns and associated ventricular tachycardias in nonischemic cardiomyopathy: implications for the ablation strategy, Circ Arrhythm Electrophysiol, 6, 875, 10.1161/CIRCEP.113.000537 · DOI · Paper page
  126. White, 2012, Utility of cardiovascular magnetic resonance in identifying substrate for malignant ventricular arrhythmias, Circ Cardiovasc imaging, 5, 12, 10.1161/CIRCIMAGING.111.966085 · DOI
  127. Ahmad, 2014, Biomarkers of myocardial stress and fibrosis as predictors of mode of death in patients with chronic heart failure, JACC Heart Fail, 2, 260, 10.1016/j.jchf.2013.12.004 · DOI
  128. Scott, 2009, Brain natriuretic peptide for the prediction of sudden cardiac death and ventricular arrhythmias: a meta-analysis, Eur J Heart Fail, 11, 958, 10.1093/eurjhf/hfp123 · DOI
  129. Levine, 2014, B-type natriuretic peptide is a major predictor of ventricular tachyarrhythmias, Heart Rhythm, 11, 1109, 10.1016/j.hrthm.2014.04.024 · DOI
  130. Berger, 2002, B-type natriuretic peptide predicts sudden death in patients with chronic heart failure, Circulation, 105, 2392, 10.1161/01.CIR.0000016642.15031.34 · DOI · Paper page
  131. Korngold, 2009, Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein as predictors of sudden cardiac death among women, Circulation, 119, 2868, 10.1161/CIRCULATIONAHA.108.832576 · DOI
  132. Patton, 2011, N-terminal pro-B-type natriuretic peptide is associated with sudden cardiac death risk: the Cardiovascular Health Study, Heart Rhythm, 8, 228, 10.1016/j.hrthm.2010.10.038 · DOI
  133. Hussein, 2013, Cardiomyocyte injury assessed by a highly sensitive troponin assay and sudden cardiac death in the community: the Cardiovascular Health Study, J Am Coll Cardiol, 62, 2112, 10.1016/j.jacc.2013.07.049 · DOI
  134. Andreasen, 2013, Mutations in genes encoding cardiac ion channels previously associated with sudden infant death syndrome (SIDS) are present with high frequency in new exome data, Can J Cardiol, 29, 1104, 10.1016/j.cjca.2012.12.002 · DOI
  135. Jabbari, 2013, New exome data question the pathogenicity of genetic variants previously associated with catecholaminergic polymorphic ventricular tachycardia, Circ Cardiovas Genetics, 481, 10.1161/CIRCGENETICS.113.000118 · DOI
  136. Paludan-Muller, 2017, Integration of 60,000 exomes and ACMG guidelines question the role of catecholaminergic polymorphic ventricular tachycardia-associated variants, Clin Genet, 91, 63, 10.1111/cge.12847 · DOI
  137. Refsgaard, 2012, High prevalence of genetic variants previously associated with LQT syndrome in new exome data, Eur J Hum Genet, 20, 905, 10.1038/ejhg.2012.23 · DOI
  138. Risgaard, 2013, High prevalence of genetic variants previously associated with Brugada syndrome in new exome data, Clin Genet, 84, 489, 10.1111/cge.12126 · DOI
  139. Costa, 2012, Combined assessment of sex- and mutation-specific information for risk stratification in type 1 long QT syndrome, Heart Rhythm, 9, 892, 10.1016/j.hrthm.2012.01.020 · DOI
  140. Hershberger, 2009, Genetic evaluation of cardiomyopathy–a Heart Failure Society of America practice guideline, J Cardiac Fail, 15, 83, 10.1016/j.cardfail.2009.01.006 · DOI · Paper page
  141. Kim, 2010, Trigger-specific risk factors and response to therapy in long QT syndrome type 2, Heart Rhythm, 7, 1797, 10.1016/j.hrthm.2010.09.011 · DOI
  142. Migdalovich, 2011, Mutation and gender-specific risk in type 2 long QT syndrome: implications for risk stratification for life-threatening cardiac events in patients with long QT syndrome, Heart Rhythm, 8, 1537, 10.1016/j.hrthm.2011.03.049 · DOI
  143. Crotti, 2012, Spectrum and prevalence of mutations involving BrS1- through BrS12-susceptibility genes in a cohort of unrelated patients referred for Brugada syndrome genetic testing: implications for genetic testing, J Am Coll Cardiol, 60, 1410, 10.1016/j.jacc.2012.04.037 · DOI · Paper page
  144. Probst, 2009, SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome, Circ Cardiovas Genetics, 2, 552, 10.1161/CIRCGENETICS.109.853374 · DOI · Paper page
  145. Dintzis, 1991, Genetic variation and the meiotic process, Res Publ Assoc Res Nerv Ment Dis, 69, 39
  146. Groeneweg, 2015, Clinical presentation, long-term follow-up, and outcomes of 1001 arrhythmogenic right ventricular dysplasia/cardiomyopathy patients and family members, Circ Cardiovasc Genet, 8, 437, 10.1161/CIRCGENETICS.114.001003 · DOI · Paper page
  147. Marcus, 2013, Genetics of arrhythmogenic right ventricular cardiomyopathy: a practical guide for physicians, J Am Coll Cardiol, 61, 1945, 10.1016/j.jacc.2013.01.073 · DOI · Paper page
  148. Quarta, 2011, Familial evaluation in arrhythmogenic right ventricular cardiomyopathy: impact of genetics and revised task force criteria, Circulation, 123, 2701, 10.1161/CIRCULATIONAHA.110.976936 · DOI · Paper page
  149. Rigato, 2013, Compound and digenic heterozygosity predicts lifetime arrhythmic outcome and sudden cardiac death in desmosomal gene-related arrhythmogenic right ventricular cardiomyopathy, Circ Cardiovasc Genet, 6, 533, 10.1161/CIRCGENETICS.113.000288 · DOI · Paper page
  150. Ackerman, 2011, HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA), Europace, 13, 1077, 10.1093/europace/eur245 · DOI · Paper page
  151. Gollob, 2011, Recommendations for the use of genetic testing in the clinical evaluation of inherited cardiac arrhythmias associated with sudden cardiac death: Canadian Cardiovascular Society/Canadian Heart Rhythm Society joint position paper, Can J Cardiol, 27, 232, 10.1016/j.cjca.2010.12.078 · DOI
  152. Kumar, 2013, Familial cardiological and targeted genetic evaluation: low yield in sudden unexplained death and high yield in unexplained cardiac arrest syndromes, Heart Rhythm, 10, 1653, 10.1016/j.hrthm.2013.08.022 · DOI
  153. Priori, 2013, HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes, Heart Rhythm, 10, 1932, 10.1016/j.hrthm.2013.05.014 · DOI · Paper page
  154. Tester, 2011, Unexplained drownings and the cardiac channelopathies: a molecular autopsy series, Mayo Clin Proc, 86, 941, 10.4065/mcp.2011.0373 · DOI
  155. Tzimas, 2016, The role of known variants of KCNQ1, KCNH2, KCNE1, SCN5A, and NOS1AP in water-related deaths, Int J Legal Med, 130, 1575, 10.1007/s00414-016-1424-2 · DOI
  156. Wang, 2014, Cardiac channelopathy testing in 274 ethnically diverse sudden unexplained deaths, Forensic Sci Int, 237, 90, 10.1016/j.forsciint.2014.01.014 · DOI
  157. Laedtke, 2012, Family physicians' awareness and knowledge of the Genetic Information Non-Discrimination Act (GINA), J Genet Couns, 21, 345, 10.1007/s10897-011-9405-6 · doi:10.1007/s10897-011-9405-6
  158. Vavolizza, 2015, Disclosing genetic information to family members about inherited cardiac arrhythmias: an obligation or a choice?, J Genet Couns, 24, 608, 10.1007/s10897-014-9783-7 · DOI
  159. Christiaans, 2009, Genetic counseling and cardiac care in predictively tested hypertrophic cardiomyopathy mutation carriers: the patients' perspective, Am J Med Genet. Part A, 149a, 1444, 10.1002/ajmg.a.32915 · DOI
  160. Hamang, 2012, Predictors of heart-focused anxiety in patients undergoing genetic investigation and counseling of long QT syndrome or hypertrophic cardiomyopathy: a one year follow-up, J Genet Counsel, 21, 72, 10.1007/s10897-011-9393-6 · DOI
  161. Dumas, 2016, Emergency PCI in post-cardiac arrest patients without ST-segment elevation pattern: insights from the PROCAT II registry, J Am Coll Cardiol Intv, 9, 1011, 10.1016/j.jcin.2016.02.001 · DOI · Paper page
  162. Cronier, 2011, Impact of routine percutaneous coronary intervention after out-of-hospital cardiac arrest due to ventricular fibrillation, Crit Care, 15, 10.1186/cc10227 · DOI
  163. Spaulding, 1997, Immediate coronary angiography in survivors of out-of-hospital cardiac arrest, N Engl J Med, 336, 1629, 10.1056/NEJM199706053362302 · DOI · Paper page
  164. Zanuttini, 2012, Impact of emergency coronary angiography on in-hospital outcome of unconscious survivors after out-of-hospital cardiac arrest, Am J Cardiol, 110, 1723, 10.1016/j.amjcard.2012.08.006 · DOI
  165. O'Gara, 2013, 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol, 61, e78, 10.1016/j.jacc.2012.11.019 · DOI · Paper page
  166. Buxton, 2000, Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators, N Engl J Med, 342, 1937, 10.1056/NEJM200006293422602 · DOI · Paper page
  167. Buxton, 2002, Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease: an analysis of patients enrolled in the multicenter unsustained tachycardia trial, Circulation, 106, 2466, 10.1161/01.CIR.0000037224.15873.83 · DOI · Paper page
  168. Costantini, 2009, The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention, J Am Coll Cardiol, 53, 471, 10.1016/j.jacc.2008.08.077 · DOI
  169. Bourke, 1991, Routine programmed electrical stimulation in survivors of acute myocardial infarction for prediction of spontaneous ventricular tachyarrhythmias during follow-up: results, optimal stimulation protocol and cost-effective screening, J Am Coll Cardiol, 18, 780, 10.1016/0735-1097(91)90802-G · DOI · Paper page
  170. Bailey, 2001, Utility of current risk stratification tests for predicting major arrhythmic events after myocardial infarction, J Am Coll Cardiol, 38, 1902, 10.1016/S0735-1097(01)01667-9 · DOI
  171. Schmitt, 2001, Value of programmed ventricular stimulation for prophylactic internal cardioverter-defibrillator implantation in postinfarction patients preselected by noninvasive risk stratifiers, J Am Coll Cardiol, 37, 1901, 10.1016/S0735-1097(01)01246-3 · DOI
  172. Hilfiker, 2015, Utility of electrophysiological studies to predict arrhythmic events, World J Cardiol, 7, 344, 10.4330/wjc.v7.i6.344 · DOI
  173. Moss, 2002, Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction, N Engl J Med, 346, 877, 10.1056/NEJMoa013474 · DOI · Paper page
  174. Bhandari, 1985, Electrophysiologic testing in patients with the long QT syndrome, Circulation, 71, 63, 10.1161/01.CIR.71.1.63 · DOI
  175. Giustetto, 2006, Short QT syndrome: clinical findings and diagnostic-therapeutic implications, Eur Heart J, 27, 2440, 10.1093/eurheartj/ehl185 · DOI · Paper page
  176. Mahida, 2015, Role of electrophysiological studies in predicting risk of ventricular arrhythmia in early repolarization syndrome, J Am Coll Cardiol, 65, 151, 10.1016/j.jacc.2014.10.043 · DOI
  177. Priori, 2002, Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia, Circulation, 106, 69, 10.1161/01.CIR.0000020013.73106.D8 · DOI · Paper page
  178. Gatzoulis, 2013, Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: reappraisal of the role of programmed ventricular stimulation, Circ Arrhythm Electrophysiol, 6, 504, 10.1161/CIRCEP.113.000216 · DOI
  179. Garson, 1993, The long QT syndrome in children. An international study of 287 patients, Circulation, 87, 1866, 10.1161/01.CIR.87.6.1866 · DOI · Paper page
  180. Hobbs, 2006, Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome, JAMA, 296, 1249, 10.1001/jama.296.10.1249 · DOI · Paper page
  181. Iribarren, 2014, Short QT in a cohort of 1.7 million persons: prevalence, correlates, and prognosis, Ann Noninvasive Electrocardiol, 19, 490, 10.1111/anec.12157 · DOI
  182. Kaufman, 2008, Risk of death in the long QT syndrome when a sibling has died, Heart Rhythm, 5, 831, 10.1016/j.hrthm.2008.02.029 · DOI
  183. Kimbrough, 2001, Clinical implications for affected parents and siblings of probands with long-QT syndrome, Circulation, 104, 557, 10.1161/hc3001.093501 · DOI
  184. Mazzanti, 2014, Novel insight into the natural history of short QT syndrome, J Am Coll Cardiol, 63, 1300, 10.1016/j.jacc.2013.09.078 · DOI · Paper page
  185. Wong, 2010, Utility of treadmill testing in identification and genotype prediction in long-QT syndrome, Circ Arrhythm Electrophysiol, 3, 120, 10.1161/CIRCEP.109.907865 · DOI
  186. Walker, 2005, Burst bicycle exercise facilitates diagnosis of latent long QT syndrome, Am Heart J, 150, 1059, 10.1016/j.ahj.2005.02.041 · doi:10.1016/j.ahj.2005.02.041
  187. Waks, 2016, Global electric heterogeneity risk score for prediction of sudden cardiac death in the general population: the Atherosclerosis Risk in Communities (ARIC) and Cardiovascular Health (CHS) Studies, Circulation, 133, 2222, 10.1161/CIRCULATIONAHA.116.021306 · DOI
  188. Priori, 2004, Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers, JAMA, 292, 1341, 10.1001/jama.292.11.1341 · DOI · Paper page
  189. Priori, 2003, Risk stratification in the long-QT syndrome, N Engl J Med, 348, 1866, 10.1056/NEJMoa022147 · DOI · Paper page
  190. Wedekind, 2009, QT interval prolongation and risk for cardiac events in genotyped LQTS-index children, Eur J Pediatr, 168, 1107, 10.1007/s00431-008-0896-6 · DOI
  191. Goldenberg, 2011, Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals, J Am Coll Cardiol, 57, 51, 10.1016/j.jacc.2010.07.038 · DOI · Paper page
  192. Nannenberg, 2012, Mortality of inherited arrhythmia syndromes: insight into their natural history, Circ Cardiovasc Genet, 5, 183, 10.1161/CIRCGENETICS.111.961102 · DOI
  193. Vaughan Williams, 1984, A classification of antiarrhythmic actions reassessed after a decade of new drugs, J Clin Pharmacol, 24, 129, 10.1002/j.1552-4604.1984.tb01822.x · DOI · Paper page
  194. Schleifer, 2015, Advances in the pharmacologic treatment of ventricular arrhythmias, Expert Opin Pharmacother, 16, 2637, 10.1517/14656566.2015.1100170 · DOI
  195. Kudenchuk, 2016, Amiodarone, lidocaine, or placebo in out-of-hospital cardiac arrest, N Engl J Med, 1711, 10.1056/NEJMoa1514204 · DOI · Paper page
  196. Mazzanti, 2016, Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3, J Am Coll Cardiol, 67, 1053, 10.1016/j.jacc.2015.12.033 · DOI · Paper page
  197. Watanabe, 2009, Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans, Nat Med, 15, 380, 10.1038/nm.1942 · DOI · Paper page
  198. Gupta, 2015, Antiarrhythmic properties of ranolazine: a review of the current evidence, Int J Cardiol, 187, 66, 10.1016/j.ijcard.2015.03.324 · DOI
  199. Zareba, 2017, Ranolazine in High-Risk ICD Patients (RAID) Trial, Presented at: Heart Rhythm Society Annual Scientific Sessions
  200. Reiter, 1998, Importance of beta blockade in the therapy of serious ventricular arrhythmias, Am J Cardiol, 82, 9I, 10.1016/S0002-9149(98)00468-8 · DOI

200 of 1163 shown

Cited by

See all 1,854

Metadata

Authors
Al-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T., Field, M. E., Fonarow, G. C., Gillis, A. M., Granger, C. B., Hammill, S. C., Hlatky, M. A., Joglar, J. A., Kay, G. N., Matlock, D. D., Myerburg, R. J., & Page, R. L.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2018-10
Volume
72
Issue
14
Pages
e91-e220
ISSN
0735-1097 (ISSN-L)
DOI
10.1016/j.jacc.2017.10.054
OpenAlex
W2940793653
Cited by
1,854
References
91
FWCI
144.51
Type
journal article
Language
en
Update notices
erratum (2018-10-02)
Open access
bronze
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. https://app.cochat.ai/papers/10.1016/j.jacc.2017.10.054
The paper
Al-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T., Field, M. E., Fonarow, G. C., Gillis, A. M., Granger, C. B., Hammill, S. C., Hlatky, M. A., Joglar, J. A., Kay, G. N., Matlock, D. D., Myerburg, R. J., & Page, R. L. (2018). 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2017.10.054

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.